Oxidase uncoupling in heme monooxygenases: Human cytochrome P450 CYP3A4 in Nanodiscs

被引:47
|
作者
Grinkova, Yelena V.
Denisov, Ilia G.
McLean, Mark A.
Sligar, Stephen G.
机构
[1] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA
[2] Univ Illinois, Dept Chem, Urbana, IL 61801 USA
关键词
Cytochrome P450; CYP3A4; Nanodiscs; P450; mechanism; Uncoupling; Oxidase pathway; LIVER MICROSOMAL CYTOCHROME-P-450; HIGH-VALENT IRON; OXYGEN ACTIVATION; LIGAND-BINDING; 3A4; COOPERATIVITY; KINETICS; HYDROXYLATION; INTERMEDIATE; OXIDATIONS;
D O I
10.1016/j.bbrc.2012.12.072
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The normal reaction mechanism of cytochrome P450 operates by utilizing two reducing,equivalents to reduce atmospheric dioxygen, producing one molecule of water and an oxygenated product in an overall stoichiometry of 2 electrons:1 dioxygen:1 product. However, three alternate unproductive pathways exist where the intermediate iron-oxygen states in the catalytic cycle can yield reduced oxygen products without substrate metabolism. The first involves release of superoxide from the oxygenated intermediate while the second occurs after input of the second reducing equivalent. Superoxide rapidly dismutates and hence both processes produce hydrogen peroxide that can be cytotoxic to the organism. In both cases, the formation of hydrogen peroxide involves the same overall stoichiometry as oxygenases catalysis. The key step in the catalytic cycle of cytochrome P450 involves scission of the oxygen-oxygen bond of atmospheric dioxygen to produce a higher valent iron-oxo state termed "Compound I". This intermediate initiates a radical reaction in the oxygenase pathway but also can uptake two additional reducing equivalents from reduced pyridine nucleotide (NADPH) and the flavoprotein reductase to produce a second molecule of water. This non-productive decay of Compound I thus yields an overall oxygen to NADPH ratio of 1:2 and does not produce hydrocarbon oxidation. This water uncoupling reaction provides one of a limited means to study the reactivity of the critical Compound I intermediate in P450 catalysis. We measured simultaneously the rates of NADPH and oxygen consumption as a function of substrate concentration during the steady-state hydroxylation of testosterone catalyzed by human P450 CYP3A4 reconstituted in Nanodiscs. We discovered that the "oxidase" uncoupling pathway is also operating in the substrate free form of the enzyme with rate of this pathway substantially increasing with the first substrate binding event. Surprisingly, a large fraction of the reducing equivalents used by the P450 system is wasted in this oxidase pathway. In addition, the overall coupling with testosterone and bromocryptine as substrates is significantly higher in the presence of anionic lipids, which is attributed to the changes in the redox potential of CYP3A4 and reductase. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:1223 / 1227
页数:5
相关论文
共 50 条
  • [41] Biophysical Techniques for Distinguishing Ligand Binding Modes in Cytochrome P450 Monooxygenases
    Podgorski, Matthew N.
    Harbort, Joshua S.
    Coleman, Tom
    Stok, Jeanette E.
    Yorke, Jake A.
    Wong, Luet-Lok
    Bruning, John B.
    Bernhardt, Paul, V
    De Voss, James J.
    Harmer, Jeffrey R.
    Bell, Stephen G.
    BIOCHEMISTRY, 2020, 59 (09) : 1038 - 1050
  • [42] Defining CYP3A4 Structural Responses to Substrate Binding. Raman Spectroscopic Studies of a Nanodisc-Incorporated Mammalian Cytochrome P450
    Mak, Piotr J.
    Denisov, Ilia G.
    Grinkova, Yelena V.
    Sligar, Stephen G.
    Kincaid, James R.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2011, 133 (05) : 1357 - 1366
  • [43] Analysis of Heterotropic Cooperativity in Cytochrome P450 3A4 Using α-Naphthoflavone and Testosterone
    Frank, Daniel J.
    Denisov, Ilia G.
    Sligar, Stephen G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (07) : 5540 - 5545
  • [44] Kinetics of electron transfer between NADPH-cytochrome P450 reductase and cytochrome P450 3A4
    Farooq, Yassar
    Roberts, Gordon C. K.
    BIOCHEMICAL JOURNAL, 2010, 432 : 485 - 493
  • [45] Structural diversification of macrolactones by substrate-flexible cytochrome P450 monooxygenases
    Lee, SK
    Basnet, DB
    Hong, JSJ
    Jung, WS
    Choi, CY
    Lee, HC
    Sohng, JK
    Ryu, KG
    Kim, DJ
    Ahn, JS
    Kim, BS
    Oh, HC
    Sherman, DH
    Yoon, YJ
    ADVANCED SYNTHESIS & CATALYSIS, 2005, 347 (10) : 1369 - 1378
  • [46] Comparison of In Vitro Metabolism of Ticlopidine by Human Cytochrome P450 2B6 and Rabbit Cytochrome P450 2B4
    Talakad, Jyothi C.
    Shah, Manish B.
    Walker, Gregory S.
    Xiang, Cathie
    Halpert, James R.
    Dalvie, Deepak
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (03) : 539 - 550
  • [47] In Silico Prediction of Cytochrome P450-Drug Interaction: QSARs for CYP3A4 and CYP2C9
    Nembri, Serena
    Grisoni, Francesca
    Consonni, Viviana
    Todeschini, Roberto
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (06):
  • [48] Expression of human cytochrome p450 3A4 gene in Schizosaccharomyces pombe
    Palabiyik, Bedia
    Karaer, Semian
    Arda, Nazli
    Toker, Sidika Erturk
    Temizkan, Guler
    Kelly, Steven
    Sarikaya, Aysegul Topal
    BIOLOGIA, 2008, 63 (03) : 450 - 454
  • [49] Expression of human cytochrome p450 3A4 gene in Schizosaccharomyces pombe
    Bedia Palabiyik
    Semian Karaer
    Nazli Arda
    Sidika Erturk Toker
    Guler Temizkan
    Steven Kelly
    Aysegul Topal Sarikaya
    Biologia, 2008, 63 : 450 - 454
  • [50] Variability in human drug metabolizing cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 activities caused by genetic variations in cytochrome P450 oxidoreductase
    Velazquez, Maria Natalia Rojas
    Parween, Shaheena
    Udhane, Sameer S.
    Pandey, Amit, V
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 515 (01) : 133 - 138